Today

Agents

Chat

Arena

Discover

More

App

YD Bio CEO Ethan Shen reports $48,895 purchase of 12,700 common shares - YDES News | Rallies

YD Bio CEO Ethan Shen reports $48,895 purchase of 12,700 common shares

YDES•2026-09-16

CEO buys 12,700 ordinary shares

YD Bio CEO and director Ethan Shen bought 12,700 ordinary shares at a weighted average price of USD 3.85.
Directly held ordinary shares rose to 11,258,331 following the purchase.
Indirect beneficial ownership totaled 43,120,858 ordinary shares.

Related News

Lamb Weston holds annual shareholder meeting

LW•2026-09-16

Fidelity National Financial corrects July refinance opened orders to +15% y/y, August to -5%

FNF•2026-09-16

Telomir Pharmaceuticals holds annual shareholder meeting

Sources

S

YD Bio CEO Ethan Shen reports $48,895 purchase of 12,700 common shares

Sec

2026-09-16

Corcept director James N. Wilson disposes of $1.11 million in common shares

CORT•2026-09-16

Brightstar Lottery to showcase lottery solutions at NASPL annual conference

BRSL•2026-09-16